Tailwind Biotech ApS: Financial statements 2024
CVR: 43630938
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
Tailwind Biotech ApS (CVR 43630938) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 852,654 and a net result of DKK -26,662. Equity in the 2024 report amounted to DKK 9,221. The solvency ratio was 19%. The company had 3 employees in the financial year.
- Gross Profit
- DKK 852,654
- Profit/Loss
- DKK -26,662
- Equity
- DKK 9,221
- Total Assets
- DKK 48,516
- Employees
- 3
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
Tailwind Biotech ApS has published its interim report for the period November 1, 2022 – December 31, 2023.
About Tailwind Biotech ApS
Tailwind Biotech ApS is a Danish company of the type Anpartsselskab based in Taastrup, founded in 2022. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Christopher Thomas Workman, Lorenzo Carvelli and Mirko Ceriani. The company's owners include HT Simonsen Holding ApS, CTW Holding ApS and LCAR Holding ApS. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK 636,591 and a net result of DKK -41,518 compared with DKK -26,662 the year before. Equity in the 2025 report amounted to DKK -32,297.